CBDGTHC Farmaceuticals, Inc

About THC Farmaceuticals, Inc (CBDG)

THC Farmaceuticals, Inc (CBDG) is a Biotechnology company headquartered in Thousand Oaks, CA, United States whose shares trade over-the-counter on the Pink tier.

THC Farmaceuticlas Inc is a clinical stage biotechnology company specializing in the discovery, development and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. We offer the combination of our proprietary developments with the expertise of our clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. THC Farmaceuticals Inc owns clinical research center and CBD manufacturing facility in California. Our business plan includes conducting cannabinoids R&D in collaboration with major cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop unique, condition-specific medications.

Products and services

THC Farmaceuticlas Inc is a clinical stage biotechnology company specializing in the discovery, development and commercialization of novel cannabinoid-based products in dental, ophthalmology and other medical disciplines. We offer the combination of our proprietary developments with the expertise of our clinicians and scientists to unlock the therapeutic properties of cannabis and its bioactive compounds. THC Farmaceuticals Inc owns clinical research center and CBD manufacturing facility in California. Our business plan includes conducting cannabinoids R&D in collaboration with major cannabis research centers worldwide with the goal of developing novel and advanced therapeutic methods for the treatment of common medical conditions with cannabis-based therapies and to conduct pre-clinical investigations and randomized, placebo-controlled trials of CBD-based compounds and develop unique, condition-specific medications. THC Farmaceuticlas has developed oral hygiene CBD based products including dental mouthwash with CBD, Toothpaste with CBD, dental prophylaxis paste with CBD, CBD Dental anxiety pills and other formulations.

CBDG key facts

Ticker symbol

CBDG

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Thousand Oaks, CA, United States

Country of incorporation

US

Year of incorporation

2005

Employees

3

Estimated market cap

$235.7K (as of May 9, 2025)

Shares outstanding

18,131,600

Reporting standard

U.S. Reporting: SEC Reporting CF

Audit status

Unaudited

Fiscal year end

9/30

Latest filing

Quarterly Report (Jun 30, 2022)

THC Farmaceuticals, Inc leadership

• Mark Grossman — Officer
• Gary Henrie — Legal Counsel

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with C